Xuehua Zhu

PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia

Kankan Wang, Ping Wang, Jiantao Shi et al. · Cancer Cell · 2010 · 163 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +10

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients

Xiaohua Wu, Lingying Wu, Beihua Kong et al. · International Journal of Gynecological Cancer · 2017 · 119 citations

Medicine, Gynecology, Oncology +17

IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response

Yi Jia, Xu Fang, Xuehua Zhu et al. · American Journal of Respiratory Cell and Molecular Biology · 2016 · 109 citations

Life Sciences, Immunology, Clinical Immunology +15

EGFR G796D mutation mediates resistance to osimertinib

Di Zheng, Min Hu, Yu Bai et al. · Oncotarget · 2017 · 106 citations · Full text

Medicine, Oncology, Pharmacology +13

Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes <i>PLZF–RAR</i> α and <i>NPM–RAR</i> α

Guoxing Cheng, Xuehua Zhu, Xiao-yuan Men et al. · Proceedings of the National Academy of Sciences · 1999 · 92 citations · Full text

Life Sciences, Genetics, Molecular Biology +17